Načítá se...
A Review of the Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies
The B-cell receptor signaling pathway plays an integral role in the proliferation and survival of malignant B cells. Targeting the B-cell receptor pathway via the inhibition of Bruton tyrosine kinase (BTK) has evolved the treatment of a variety of B-cell malignancies, including chronic lymphocytic l...
Uloženo v:
| Vydáno v: | J Adv Pract Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Harborside Press LLC
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8163255/ https://ncbi.nlm.nih.gov/pubmed/34123480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2021.12.4.8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|